nucleic acid amplification
Cue Health Shutting Down Operations
The firm said in an updated notice filed with the state of California this week that 218 employees will be laid off.
FDA Warns Against Use of Cue Health COVID-19 Tests
The agency said that the firm's SARS-CoV-2 tests for over-the-counter and point-of-care use have an increased risk of false results.
FDA Seeks More Data in Cue Health De Novo Request for RSV Molecular Test
The FDA determined that Cue's test does not meet the criteria for a Class I or Class II medical device for over-the-counter use and wants more data from the company.
Cue Health CEO Steps Down as Company Begins Business Review
The company said the comprehensive review is intended to assess opportunities to refine and strengthen Cue's overarching strategy and cost structure.
Genomtec Receives $5.5M to Develop Cancer Mutation Detection Technology
The company will develop an automated system for detecting mutations based on lab-on-chip solutions and isothermal nucleic acid amplification.
Mar 30, 2022
Nov 10, 2021
Cue Health Revenues up Massively in Q3
Jan 31, 2020
NeuMoDx T. Vaginalis, M. Genitalium Assay CE Marked
Oct 2, 2019